Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
about
An update on the hyper-IgE syndromesThe Hyper-IgE Syndromes: Lessons in Nature, From Bench to BedsideTranscription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.A rare primary immunodeficiency.A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signalingA critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.Hyperimmunoglobulin E syndromes in pediatrics.Targeting the interleukin-6/Jak/stat pathway in human malignanciesLarge B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel DiseaseSTAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyAblation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo.Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.Genetic Interactions of STAT3 and Anticancer Drug Development.Germline mutations predisposing to diffuse large B-cell lymphoma.
P2860
Q27021598-55E22677-E289-4B06-A52D-2F5CD3FC62BDQ28282449-185A0ABD-9CE8-4351-A65E-7D7067984DD2Q33917198-1F4F0F0C-6B41-4239-A616-75D14B1E70D4Q34235618-8CC7CC65-87BA-4ECF-A34B-95C518CDD0B0Q34826329-4D58E9EE-F2B9-418D-B111-99DF694589C7Q35586049-8EAC7FAD-DB79-49E7-900C-1C92FC9BD8F4Q35804716-8D69CC02-E361-4140-BE65-B6A4E115DF0AQ35925127-0ED6E65F-C9CC-4690-B004-6301774BF431Q36161965-CD06C613-1269-4DC8-A8D8-5B8EFD2A75FCQ36318148-54EB801F-333D-42A0-ABA8-628A3798675DQ36685267-AEB834AD-2478-4D7A-B063-94257611A934Q36923083-95B80A80-E240-4413-8C69-9F4B076B2ABFQ37168674-A9B5D466-C482-4DCF-B10F-73D6932AC13DQ37202661-677E9F08-8A4B-4F05-800E-8F2F0B364DBCQ38198930-C3FD8E0E-E693-436B-8B0B-FFBA358BB745Q38756189-8D9150EA-D9D3-4CB6-AEBB-AAE981CCB336
P2860
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@en
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@nl
type
label
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@en
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@nl
prefLabel
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@en
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@nl
P2093
P2860
P1476
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
@en
P2093
Attila Kumánovics
Harry R Hill
Heather Gilbert
Melissa H Cessna
Nancy H Augustine
Sherrie L Perkins
P2860
P2888
P304
P356
10.1007/S10875-010-9452-Z
P577
2010-09-22T00:00:00Z